you are here: HomeNewscoronavirus

EXCLUSIVE | We are feeling perfectly fine: Infosys co-founder NR Narayana Murthy after getting vaccinated

The vaccination process was seamless, and we did not have any problem in registering, says Infosys co-founder NR Narayana Murthy after getting vaccinated against COVID-19.

March 02, 2021 / 09:54 AM IST
Infosys co-founder NR Narayana Murthy (Image: Reuters)

Infosys co-founder NR Narayana Murthy (Image: Reuters)

Infosys co-founder NR Narayana Murthy and his wife Sudha Murty were among the prominent citizens of Bengaluru who got vaccinated on March 1, after India expanded its vaccination drive to cover senior citizens and those over 45 years with co-morbidities.

Murthy shared his experience in getting a vaccine jab with Moneycontrol's Chandra R Srikanth.

Q: Have you received the vaccine? Are you feeling fine?

A: Yes, Sudha and I took our vaccine for COVID today at Narayana Hrudayala. Dr Devi Shetty’s team was extremely kind, professional, and helpful. We are very grateful to Devi and his team. We are feeling perfectly fine.

Q: Was the whole process seamless, as many people said they faced technical glitches?


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

A: It was seamless. We did not have any problem in registering.

Q: Were you administered Covaxin by Bharat Biotech or Covishield by Serum Institute of India?

A: We were given Covishield by the Serum Institute.

Q: Has this given you the confidence to travel again?

A: We have to complete the two doses before we can start attending the office. We will do as the experts advise us, the citizens, to do in terms of social distancing, masks and travel.

Q: How can the government and private sector work together to vaccinate Indians at scale?

The government is already working with several private hospitals to administer the vaccine. This is good since the people, who can afford, can use the private sector and make sure that there are no huge crowds at the public hospitals for people that cannot afford. I have confidence that there will be a larger number of private hospitals participating in vaccination as we move forward.

Q: Is the pricing at Rs 250 per shot reasonable?

A: I have not built any economic model for this. So, I cannot comment. Only those who have done the modelling can comment.
Chandra R Srikanth is Editor- Tech, Startups, and New Economy

stay updated

Get Daily News on your Browser